Major response to paclitaxel combined with irradiation as second-line therapy in metastatic angiosarcoma of the face and scalp.
Hofmann
U B
UB
Wobser
M
M
Kneitz
H
H
Kleine
P
P
Becker
J C
JC
Bröcker
E B
EB
Ugurel
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000379:methods; D004317:Doxorubicin / Q000008:administration & dosage; D005153:Facial Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D005546:Forehead; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006394:Hemangiosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage; D012535:Scalp; D016896:Treatment Outcome
D004317:Doxorubicin; D017239:Paclitaxel